Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXII. Predictors of time to the occurrence of initial damage
- PMID: 15476246
- DOI: 10.1002/art.20578
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXII. Predictors of time to the occurrence of initial damage
Abstract
Objective: To examine the factors predisposing to initial damage in patients in the LUMINA (lupus in minorities: nature versus nurture) cohort, a multiethnic cohort of patients with systemic lupus erythematosus (SLE) in the US.
Methods: One hundred fifty-eight LUMINA patients with no damage at baseline (time 0) according to the Systemic Lupus International Collaborating Clinics Damage Index (SDI) and with disease duration > 6 months were followed up for a median of 24 months (range 5-112 months). Damage was assessed from time 0 to the last visit. Predictors of time to initial damage were examined by univariable and multivariable Cox proportional hazard regression models. Results were reported as hazard ratios (HRs); HR values > or = 1 indicated a shorter time to initial damage, and values < 1 indicated a longer time.
Results: Initial damage occurred in 54 patients (34%), of whom 21 were Hispanics from Texas (39%), 2 were Hispanics from Puerto Rico (4%), 21 were African Americans (39%), and 10 were Caucasians (19%). The most frequently observed initially involved SDI domains (and items) were as follows: renal (primarily proteinuria) in Hispanics from Texas and African Americans, integument (primarily scarring alopecia) in Hispanics from Puerto Rico, and ocular (primarily cataracts) in Caucasians. By multivariable analyses, independent predictors of a shorter time to initial damage were Hispanic ethnicity from Texas (HR 2.11, 95% confidence interval [95% CI] 1.15-3.88), greater disease activity according to the Systemic Lupus Activity Measure (HR 1.09, 95% CI 1.04-1.15), the occurrence of thrombotic events in visceral and/or peripheral veins or arteries (HR 7.66, 95% CI 2.13-27.51), and prednisone at a dosage of < 10 mg/day (HR 2.53, 95% CI 1.15-5.55). Prednisone at a dosage of 10-30 mg/day was found to be protective against the occurrence of initial damage (HR 0.46, 95% CI 0.22-0.96).
Conclusion: Given that damage is a predictor of further damage, identifying the factors that may herald the occurrence of initial damage has very practical implications for the management of patients with SLE. These results need to be considered when evaluating therapies for SLE.
Copyright 2004 American College of Rheumatology
Similar articles
-
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events.Arthritis Rheum. 2004 Dec;50(12):3947-57. doi: 10.1002/art.20622. Arthritis Rheum. 2004. PMID: 15593203
-
Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual.Arthritis Rheum. 2001 Dec;44(12):2797-806. doi: 10.1002/1529-0131(200112)44:12<2797::aid-art467>3.0.co;2-9. Arthritis Rheum. 2001. PMID: 11762940
-
Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort.Arthritis Care Res (Hoboken). 2010 Mar;62(3):393-400. doi: 10.1002/acr.20097. Arthritis Care Res (Hoboken). 2010. PMID: 20391486 Free PMC article.
-
Understanding Risk Factors for Poor Outcomes in a Multiethnic Longitudinal Cohort: The LUMINA (Lupus in Minorities: Nature vs. Nurture) Experience (LUMINA LXXXII).Rheum Dis Clin North Am. 2021 Feb;47(1):55-64. doi: 10.1016/j.rdc.2020.09.002. Epub 2020 Oct 29. Rheum Dis Clin North Am. 2021. PMID: 34042054 Review.
-
What have we learned from a 10-year experience with the LUMINA (Lupus in Minorities; Nature vs. nurture) cohort? Where are we heading?Autoimmun Rev. 2004 Jun;3(4):321-9. doi: 10.1016/j.autrev.2003.11.005. Autoimmun Rev. 2004. PMID: 15246029 Review.
Cited by
-
Effect of age, menopause and cyclophosphamide use on damage accrual in systemic lupus erythematosus patients from LUMINA, a multiethnic US cohort (LUMINA LXIII).Lupus. 2009 Feb;18(2):184-6. doi: 10.1177/0961203308098988. Lupus. 2009. PMID: 19151125 Free PMC article. No abstract available.
-
Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations.Arthritis Rheum. 2012 Nov;64(11):3687-94. doi: 10.1002/art.34650. Arthritis Rheum. 2012. PMID: 22886787 Free PMC article.
-
Cardiovascular involvement in autoimmune diseases.Biomed Res Int. 2014;2014:367359. doi: 10.1155/2014/367359. Epub 2014 Jul 22. Biomed Res Int. 2014. PMID: 25177690 Free PMC article. Review.
-
Periodontal findings in systemic lupus erythematosus patients and healthy controls.Saudi Med J. 2015 Apr;36(4):463-8. doi: 10.15537/smj.2015.4.10746. Saudi Med J. 2015. PMID: 25828284 Free PMC article.
-
Rituximab therapy in lupus nephritis: current clinical evidence.Clin Rev Allergy Immunol. 2011 Jun;40(3):159-69. doi: 10.1007/s12016-010-8205-3. Clin Rev Allergy Immunol. 2011. PMID: 20419398 Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical